Evidence on the pharmacological treatment of ADHD

Duration: 23 mins Publication Date: 9 Jul 2024 Next Review Date: 9 Jul 2027 DOI: 10.13056/acamh.13686

Description

In this talk, Professor Samuele Cortese discusses current pharmacological treatments for ADHD, referencing the latest NICE guidelines and a significant European ADHD Guidelines Group network meta-analysis. He explores the efficacy and tolerability of ADHD medications, specifically comparing stimulants like methylphenidate and amphetamines. The analysis addresses both short-term effects and long-term implications, highlighting the importance of balancing efficacy with tolerability in clinical practice.

Learning Objectives

A. To understand the sequence of pharmacological treatments for ADHD as recommended by NICE guidelines, starting with methylphenidate.
B. To evaluate the efficacy and tolerability of different ADHD medications using network meta-analysis findings.
C. To assess the long-term effects of ADHD medications on quality of life and other serious outcomes through meta-analysis and observational studies.